Spyre Therapeutics, Inc. - Enterprise Value

The Enterprise Value as of June 2026 (TTM) for Spyre Therapeutics, Inc. (SYRE) is 5.24B

According to Spyre Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 5.24B. This represents a change of -31.58% compared to the average of 7.66B of the last 4 quarters.

Spyre Therapeutics, Inc. (SYRE) Historical Enterprise Value (quarterly & annually)

How has SYRE Enterprise Value performed in the past?

The mean historical Enterprise Value of Spyre Therapeutics, Inc. over the last ten years is 1.33B. The current 5.24B Enterprise Value has changed 39.32% with respect to the historical average. Over the past ten years (40 quarters), SYRE's Enterprise Value was at its highest in in the March 2026 quarter at 17.36B. The Enterprise Value was at its lowest in in the June 2023 quarter at -187908015.60.

Spyre Therapeutics, Inc. (SYRE) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Spyre Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Spyre Therapeutics, Inc. (SYRE) Average Enterprise Value

How has SYRE Enterprise Value performed in the past?

The current Enterprise Value of Spyre Therapeutics, Inc. (SYRE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Spyre Therapeutics, Inc. (SYRE) Enterprise Value vs. Peers

How is SYRE’s Enterprise Value compared to its peers?

Spyre Therapeutics, Inc.’s Enterprise Value is greater than Pharvaris N.V. (1.75B), greater than Immunome, Inc. (1.21B), greater than Wave Life Sciences Ltd. (656.32M), greater than Intellia Therapeutics, Inc. (1.70B), greater than Zymeworks Inc. (1.48B), greater than Maze Therapeutics, Inc. (1.28B), greater than AbCellera Biologics Inc. (1.75B), greater than Upstream Bio, Inc. (244.51M), greater than Ardelyx, Inc. (1.67B), greater than Celldex Therapeutics, Inc. (2.12B),

Build a custom stock screener for Spyre Therapeutics, Inc. (SYRE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Spyre Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Spyre Therapeutics, Inc. (SYRE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Spyre Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.